Tong Ren Tang Technologies Co Ltd Class H TGRNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.49
- Day Range
- $0.40–0.40
- 52-Week Range
- $0.40–0.55
- Bid/Ask
- $0.00 / $414,400.44
- Shares Outstanding
- 1.28B
- Market Cap
- $511.22M
- Volume/Avg
- 600 / 600
Key Statistics
- Price/Earnings (Normalized)
- 11.64
- Price/Sales
- 0.62
- Dividend Yield (Trailing)
- 6.61%
- Dividend Yield (Forward)
- 6.61%
- Dividend Payment Schedule
- Aug
- Total Yield
- 6.61%
Company Profile
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,801
- Website
- https://www.tongrentangkj.com
Valuation
|
Metric
|
TGRNF
|
|---|---|
Price/Earnings (Normalized) | 11.64 |
Price/Book Value | 0.48 |
Price/Sales | 0.62 |
Price/Cash Flow | 2.96 |
Price/Earnings
TGRNF
Financial Strength
|
Metric
|
TGRNF
|
|---|---|
Quick Ratio | 3.08 |
Current Ratio | 5.08 |
Interest Coverage | 12.71 |
Quick Ratio
TGRNF
Profitability
|
Metric
|
TGRNF
|
|---|---|
Return on Assets (Normalized) | 4.03% |
Return on Equity (Normalized) | 7.65% |
Return on Invested Capital (Normalized) | 4.56% |
Return on Assets
TGRNF
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|>XMs!J#r | LOCK|^< | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|P@TqwJj | LOCK|>c | $644B | |||
| AbbVie Inc
ABBV
| LOCK|?b^G>yj | LOCK|fV& | $504B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|Zz^w<Y#j | LOCK|@! | $380B | |||
| Merck & Co Inc
MRK
| LOCK|dRc%z!& | LOCK|#^ | $363B | |||
| Novartis AG ADR
NVS
| LOCK|@$@$&#@n | LOCK|j< | $297B | |||
| AstraZeneca PLC
AZN
| LOCK|%lTgfHg | LOCK|QPV | $270B | |||
| Amgen Inc
AMGN
| LOCK|VVC?s$< | LOCK|xf | $242B | |||
| Gilead Sciences Inc
GILD
| LOCK|<#C<^pY | LOCK|bS | $195B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|@>N?>>! | LOCK|ln | $176B |
United States